RETINALGENIX TECHNOLOGIES INC. Deferred Tax Assets, Net of Valuation Allowance
RETINALGENIX TECHNOLOGIES INC. (RTGN) had Deferred Tax Assets, Net of Valuation Allowance of $0 as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2026-04-15
- 2025-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2024-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2023-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00; Deferred Tax Assets, Net of Valuation Allowance as first filed $3.32M.
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $2.69M; Deferred Tax Assets, Net of Valuation Allowance as first filed $1.71M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance | Deferred Tax Assets, Net of Valuation Allowance as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-04-15 | |
| 2024-12-31 | $0.00 10-K · filed 2026-04-15 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 | $3.32M 10-K · filed 2024-04-01 |
| 2022-12-31 | $2.69M 10-K · filed 2024-04-01 | $1.71M 10-K · filed 2023-03-31 |
| 2021-12-31 | $1.19M 10-K/A · filed 2023-06-15 | $1.18M 10-K · filed 2022-04-15 |
| 2020-12-31 | $789.00K 10-K · filed 2022-04-15 | $788.00K 10-Q · filed 2021-11-22 |
| 2019-12-31 | $232.00K 10-Q · filed 2021-11-22 |